Welcome to MS Views and News blog


MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

March 17, 2026

Online Survey: Stress and MS – from the National MS Society

  • MS Research Study and Reports
    /
  • National MS Society Related
    /
March 2026   Kenneth, diagnosed in 2014   Researchers are committed to finding solutions for everyone affected by MS. Without…
MS Research Study and Reports

March 17, 2026

High-Altitude Gene Helps Heal Myelin Damage

  • Misc. MS Related
    /
  • Myelin Repair
    /
Neuroscience·March 13, 2026 Summary: Evolutionary adaptations that allow animals like yaks and Tibetan antelopes to thrive at 14,700 feet may provide…
Misc. MS Related

March 11, 2026

Talking Biosimilars – Unlocking Patient access through coordinated action

  • Biosimilars
    /
  • MS Drug Therapies
    /
FIRST, Click this link https://www.sandoz.com/business/biosimilars/talking-biosimilars/ to access the report. After the website page opens, CLICK the image that reads Download,,…
Biosimilars

March 5, 2026

Beyond One Drug: What the Tolebrutinib Decision Teaches Us About Progressive MS Trials.

  • Healthcare Perspectives
    /
  • MS Drug Therapies
    /
Reflections on risk, biology, and the trials progressive MS now demands Feb 03, 2026 – by: Leorah Freeman, MD, PhD…
Healthcare Perspectives

March 2, 2026

MS Trial Alert: Investigators Recruiting Nationwide for Study Comparing AHSCT to Other Therapies in Active Relapsing MS

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Stem Cell Related
    /
Researchers are committed to finding solutions for everyone affected by MS. Without participants—like you—in research studies, MS research would come…
MS Research Study and Reports

March 2, 2026

Genentech’s Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1)

  • BTK Inhibitors
    /
  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
– FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by 51% compared to teriflunomide in relapsing…
BTK Inhibitors

March 1, 2026

Eating well with MS can be an effective in managing symptoms

  • Nutrition
    /
While there isn’t an established multiple sclerosis (MS) diet plan, eating well with MS can be an effective way to manage symptoms…
Nutrition

March 1, 2026

Pseudobulbar affect in MS

  • Multiple Sclerosis (MS) Symptoms
    /
Prevalence and association with symptoms in multiple sclerosis Background We sought to determine the prevalence of pseudobulbar affect (PBA) in…
Multiple Sclerosis (MS) Symptoms

March 1, 2026

Catch-up on Our Mental Wellness Chat Series

  • Mental Wellness
    /
  • Mental Health
    /
A series designed by an MS patient, to benefit countless amounts of others, living with MS CLICK here, to watch…
Mental Wellness

March 1, 2026

High-dose vitamin D can help delay progression to MS

  • Vitamins and Supplements
    /
Fewer patients on vitamin D had evidence of disease activity at 2 years in study Taking high-dose cholecalciferol (vitamin D)…
Vitamins and Supplements

Categories

Latest Blog Posts